Zhenyang Zhao1, Pei Xu1, Zuliang Jie2, Yiqin Zuo1, Bo Yu1, Lynn Soong2, Jiaren Sun2, Yan Chen1, Jiyang Cai3. 1. Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas, United States. 2. Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States. 3. Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas, United States Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, Texas, United States.
Abstract
PURPOSE: Chronic inflammation is a key factor contributing to the progression of age-related macular degeneration (AMD). The goals of the current study were to develop an improved mouse model with retinal pathologic features similar to those of AMD and to characterize the immunoreactive cells in the outer retina and choroid during degeneration of the retinal pigment epithelium (RPE). METHODS: Mice deficient in nuclear erythroid 2-related factor 2 (Nrf2) at 12 months of age were fed a high-fat, cholesterol-rich diet for up to 16 weeks. Ocular phenotype was monitored by optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) in live animals, and was further validated by retinal histopathology. Immunofluorescence staining of either cryosections or RPE flat mounts was used to define immunoreactive cells. Flow cytometry analyses were further performed to define the subsets of intraocular T lymphocytes. RESULTS: After 16 weeks on a high-fat (HF) diet, 58% of the eyes from Nrf2-/- mice had progression of retinal lesions. Major histocompatibility complex class II (MHC II)-positive microglia, FoxP3+ regulatory T cells (Tregs), and CD3+ IL-17-producing T cells were detected in either the retina or sub-RPE space. Flow cytometry analyses further revealed that most of the IL-17-producing cells were CD3+ CD4- TCRγδ+ cells. CONCLUSIONS: The results suggest that the T cell-mediated immune responses played important roles in controlling the progression of AMD-like phenotype in Nrf2-deficient mice. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE:Chronic inflammation is a key factor contributing to the progression of age-related macular degeneration (AMD). The goals of the current study were to develop an improved mouse model with retinal pathologic features similar to those of AMD and to characterize the immunoreactive cells in the outer retina and choroid during degeneration of the retinal pigment epithelium (RPE). METHODS:Mice deficient in nuclear erythroid 2-related factor 2 (Nrf2) at 12 months of age were fed a high-fat, cholesterol-rich diet for up to 16 weeks. Ocular phenotype was monitored by optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) in live animals, and was further validated by retinal histopathology. Immunofluorescence staining of either cryosections or RPE flat mounts was used to define immunoreactive cells. Flow cytometry analyses were further performed to define the subsets of intraocular T lymphocytes. RESULTS: After 16 weeks on a high-fat (HF) diet, 58% of the eyes from Nrf2-/- mice had progression of retinal lesions. Major histocompatibility complex class II (MHC II)-positive microglia, FoxP3+ regulatory T cells (Tregs), and CD3+ IL-17-producing T cells were detected in either the retina or sub-RPE space. Flow cytometry analyses further revealed that most of the IL-17-producing cells were CD3+ CD4- TCRγδ+ cells. CONCLUSIONS: The results suggest that the T cell-mediated immune responses played important roles in controlling the progression of AMD-like phenotype in Nrf2-deficient mice. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Entities:
Keywords:
IL-17; T lymphocyte; age-related macular degeneration; inflammation
Authors: Ana M Santos; David Martín-Oliva; Rosa M Ferrer-Martín; Mohamed Tassi; Ruth Calvente; Ana Sierra; Maria-Carmen Carrasco; José L Marín-Teva; Julio Navascués; Miguel A Cuadros Journal: J Comp Neurol Date: 2010-02-15 Impact factor: 3.215
Authors: Yan Cui; Hui Shao; Chen Lan; Hong Nian; Rebecca L O'Brien; Willi K Born; Henry J Kaplan; Deming Sun Journal: J Immunol Date: 2009-07-01 Impact factor: 5.422
Authors: Ulrich F O Luhmann; Scott Robbie; Peter M G Munro; Susie E Barker; Yanai Duran; Vy Luong; Frederick W Fitzke; James W B Bainbridge; Robin R Ali; Robert E MacLaren Journal: Invest Ophthalmol Vis Sci Date: 2009-07-02 Impact factor: 4.799
Authors: Tomasz Boczek; Evan G Cameron; Wendou Yu; Xin Xia; Sahil H Shah; Boris Castillo Chabeco; Joana Galvao; Michael Nahmou; Jinliang Li; Hrishikesh Thakur; Jeffrey L Goldberg; Michael S Kapiloff Journal: J Neurosci Date: 2019-05-16 Impact factor: 6.167
Authors: Sheldon Rowan; Shuhong Jiang; Min-Lee Chang; Jonathan Volkin; Christa Cassalman; Kelsey M Smith; Matthew D Streeter; David A Spiegel; Carlos Moreira-Neto; Naila Rabbani; Paul J Thornalley; Donald E Smith; Nadia K Waheed; Allen Taylor Journal: Free Radic Biol Med Date: 2020-02-14 Impact factor: 7.376
Authors: Yan Wang; Evan G Cameron; Jinliang Li; Travis L Stiles; Michael D Kritzer; Rahul Lodhavia; Jonathan Hertz; Tu Nguyen; Michael S Kapiloff; Jeffrey L Goldberg Journal: EBioMedicine Date: 2015-10-28 Impact factor: 8.143